Baker Bros Boosts Its KYMR, REPL Stakes January 11, 2024 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The largest insider buy on today’s list comes in a 13G filing by Baker Bros Advisors LP. The hedge fund increased its ownership position in Kymera Therapeutics Inc $KYMR from 9.2% to 10.8%. Read More
Biotechnology Value Fund Ups Its KYMR Stake to 10% January 10, 2024 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The largest insider buy on today’s list comes in a 13G filing by Biotechnology Value Fund. The investment partnership increased its stake in Kymera Therapeutics Inc $KYMR from 8.45% to 10%. Read More
CEO Wentworth Buys 10,000 WBA Shares January 9, 2024 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The largest insider buy on today’s list comes in a Form 4 filing by Timothy C. Wentworth, CEO of Walgreens Boots Alliance $WBA. Wentworth reported a purchase of 10,000 WBA shares, equivalent to $242,220. Read More
Broadwood Partners Reports a $6.4 Million STAA Purchase January 8, 2024 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The largest insider buy on today’s list comes in a Form 4 filing by Broadwood Partners LP. The investment firm reported a purchase of roughly $6.4 million in STAAR Surgical Company $STAA. Read More
Point72 Takes a 5.4% Stake in CCCC January 5, 2024 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The only transaction on today’s list comes in a 13G filed by Point72 Asset Management. The hedge fund revealed an initial stake of 5.40% in C4 Therapeutics Inc $CCCC. Read More
Riposte Capital Raises Its SBOW Stake to 9.7% January 4, 2024 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The only transaction on today’s list comes in a 13G filed by Riposte Capital. The firm increased its stake in SilverBow Resources $SBOW from 7.75% to 9.70%. Read More
Director Lynch Reports Another Large GSAT Purchase January 3, 2024 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The largest transaction on today’s list comes in a Form 4 filing by James F. Lynch, director of Globalstar Inc $GSAT. Lynch reported a purchase of GSAT shares with a total value of $963,700. Read More
Venrock Healthcare Capital Reports a $6.4 Million KALV Purchase January 2, 2024 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The most significant transaction on today’s list comes in a Form 4 filing by Venrock Healthcare Capital Partners. The firm reported a purchase of roughly $6.4 million in KalVista Pharmaceuticals Inc $KALV. Read More
Director Satter Reports a $1 Million ANNX Purchase December 29, 2023 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The most significant transaction on today’s list comes in a Form 4 filing by Annexon Inc $ANNX director Muneer A. Satter. Satter reported a purchase of $1 million in $ANNX. Read More
Yakira Capital Reports an SRG Purchase December 28, 2023 JC Parets From the Desk of Steve Strazza and Alfonso Depablos This is a notoriously slow week for the market, and our insider filings and options flow scans reflect it. We only have a single Form 4 today, and it comes from Yakira Capital Management Inc. The investment firm revealed a purchase of $130,899 in Seritage Growth Properties $SRG. Read More
CEO Hightower Reports a Big HPK Purchase December 27, 2023 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The most significant transaction on today’s list comes in a Form 4 filing by the CEO of HighPeak Energy Inc $HPK, Jack Hightower. Hightower reported the acquisition of 150,442 HPK shares, equivalent to roughly $2.1 million. Read More
Director Rakolta Reports a Large ADC Buy December 26, 2023 JC Parets From the Desk of Steve Strazza and Alfonso Depablos The most significant transaction on today’s list comes in a Form 4 filing by John Rakolta Jr,, director of Agree Realty Corporation $ADC. Rakolta reported a ADC purchase with a total value of $832,627. Read More
